Ticker
ARDXCompany Name
ARDELYX INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Cash and Equivalents | Cash Ratio | Current Liabilities |
---|---|---|---|
6/30/2025 | $ 90.05M | 1.1 | $ 81.72M |
3/31/2025 | $ 30.81M | 0.41 | $ 75.84M |
12/31/2024 | $ 64.93M | 0.83 | $ 77.83M |
9/30/2024 | $ 47.43M | 0.67 | $ 70.5M |
6/30/2024 | $ 41.89M | 0.67 | $ 62.44M |
3/31/2024 | $ 36.15M | 0.64 | $ 56.9M |
12/31/2023 | $ 21.47M | 0.43 | $ 50.39M |
9/30/2023 | $ 33.77M | 0.78 | $ 43.53M |
6/30/2023 | $ 30.06M | 0.49 | $ 61.69M |
3/31/2023 | $ 92.49M | 1.47 | $ 63.06M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
CashnEq / LiabilitesC
(=) Cash Ratio
Cash Ratio for ARDELYX INC is calculated as follows: CashnEq [ $ 91.01M ] / LiabilitesC [ $ 16.53M ]
(=) Cash Ratio [ 5.5 ]
Minimum
Mar 31, 2025
Maximum
Sep 30, 2020
Average
Median
filtered constituents | 3.13K |
---|---|
min | 0 |
max | 2.69 |
average | 0.62 |
median | 0.39 |
std | 0.63 |